[
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-1",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#definitiongeneral216224",
    "clean_content": "Definition / general\n\n* A novel indolent pancreatic neoplasm with unique morphologic / immunophenotypic features and a distinct methylation pattern, different from both epithelial and mesenchymal neoplasms described in other anatomical sites ([Mod Pathol 2020;33:456](31383964))* First described in 2020 ([Mod Pathol 2020;33:456](31383964))"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-2",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#essentialfeatures216225",
    "clean_content": "Essential features\n\n* Indolent* Well circumscribed tumor with a geographic pattern of epithelioid cell nests alternating with spindle cell fascicles* Vimentin (diffuse), CD99 (diffuse) and cytokeratin (AE1 / AE3 and CK18, dot-like) expression* Lack of abnormalities in any of key genetic drivers* Mesenchymal transcriptomic features and distinct methylation signature"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-3",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#epidemiology216228",
    "clean_content": "Epidemiology\n\n* Mean age: 43 years ([Mod Pathol 2020;33:456](31383964))* F:M = 3:1 ([Mod Pathol 2020;33:456](31383964))"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-4",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#sites216229",
    "clean_content": "Sites\n\n* Mostly occurs in head and neck of the pancreas ([Mod Pathol 2020;33:456](31383964))"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-5",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#clinicalfeatures216233",
    "clean_content": "Clinical features\n\n* Nonspecific symptoms"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-6",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Laboratory",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#laboratory216235",
    "clean_content": "Laboratory\n\n* Serum tumor markers (CA19.9 and CEA) within normal limits"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-7",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#prognosticfactors216238",
    "clean_content": "Prognostic factors\n\n* None known; exhibits indolent behavior ([Mod Pathol 2020;33:456](31383964))"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-8",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#casereports390076",
    "clean_content": "Case reports\n\n* 31 year old woman with suspected solid pseudopapillary neoplasm of the pancreatic tail ([Pancreas 2021;50:e47](34016901))"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-9",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#grossdescription216242",
    "clean_content": "Gross description\n\n* Well circumscribed and solid, usually confined to the pancreatic parenchyma* White-tan and firm cut surface* Median tumor size: 1.8 cm ([Mod Pathol 2020;33:456](31383964))"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-10",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#grossimages216243",
    "clean_content": "Gross images\n\nImages hosted on other servers:  \n\n[![Well circumscribed solid lesion](https://www.pathologyoutlines.com/thumb/pancreassclerosingepitpmc01.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000300/figure/F1/)\n\nWell circumscribed solid lesion"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-11",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#microscopichistologicdescription216246",
    "clean_content": "Microscopic (histologic) description\n\n* Solid neoplasms associated with extensive fibrosis and dense lymphoid aggregates at the periphery ([Mod Pathol 2020;33:456](31383964))* Entrapped pancreatic parenchyma may be seen at the periphery or within the tumor* Density of tumor cells varies significantly, not only among tumors but also throughout each tumor, creating a geographic appearance of hypercellular and hypocellular areas with collagenous stroma* No true epithelial structures such as glands, papillae or pseudopapillae ([Mod Pathol 2020;33:456](31383964))* Most cells are epithelioid to spindled with scant cytoplasm and round to oval nuclei with open chromatin\n          + Others display more irregular, hyperchromatic nuclei* Occasional mitotic figures may be seen"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-12",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#microscopichistologicimages216247",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Olca Basturk, M.D.  \n\n[![Overall appearance](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk01.jpg)](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk01.jpg)\n\nOverall appearance\n\n[![Well circumscribed lesion](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk02.jpg)](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk02.jpg)\n\nWell circumscribed lesion\n\n[![Peripheral dense lymphoid aggregates](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk03.jpg)](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk03.jpg)\n\nPeripheral dense lymphoid aggregates\n\n[![Entrapped pancreatic parenchyma](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk04.jpg)](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk04.jpg)\n\nEntrapped pancreatic parenchyma\n\n[![Hypercellular and hypocellular areas](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk05.jpg)](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk05.jpg)\n\nHypercellular and hypocellular areas\n\n  \n\n[![Sheets of epithelioid cells](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk06.jpg)](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk06.jpg)\n\nSheets of epithelioid cells\n\n[![Atypical spindle cells](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk07.jpg)](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk07.jpg)\n\nAtypical spindle cells\n\n[![Dense hyaline fibrosis](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk08.jpg)](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk08.jpg)\n\nDense hyaline fibrosis\n\n[![Membranous CD99 expression](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk09.jpg)](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk09.jpg)\n\nMembranous CD99 expression\n\n[![Dot-like CK18 expression](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk10.jpg)](https://www.pathologyoutlines.com/imgau/pancreassclerosingepitbasturk10.jpg)\n\nDot-like CK18 expression"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-13",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#positivestains216253",
    "clean_content": "Positive stains\n\n* [Vimentin](https://www.pathologyoutlines.com/topic/stainsvimentin.html), [CD99](https://www.pathologyoutlines.com/topic/cdmarkerscd99.html), [AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html), [CK18](https://www.pathologyoutlines.com/topic/stainsck18.html) (dot-like) ([Mod Pathol 2020;33:456](31383964))"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-14",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#negativestains216254",
    "clean_content": "Negative stains\n\n* [Synaptophysin](https://www.pathologyoutlines.com/topic/stainssynaptophysin.html), [chromogranin](https://www.pathologyoutlines.com/topic/stainschromogranin.html), abnormal [beta catenin](https://www.pathologyoutlines.com/topic/stainsbetacatenin.html), [progesterone receptor](https://www.pathologyoutlines.com/topic/stainsprog.html), [CD10](https://www.pathologyoutlines.com/topic/cdmarkerscd10.html), [trypsin](https://www.pathologyoutlines.com/topic/stainstrypsin.html), [chymotrypsin](https://www.pathologyoutlines.com/topic/stainsalpha1antichymo.html), [MUC4](https://www.pathologyoutlines.com/topic/stainsmuc2.html#muc4271809), [desmin](https://www.pathologyoutlines.com/topic/stainsdesmin.html), [myogenin](https://www.pathologyoutlines.com/topic/stainsmyogenin.html), [INI1](https://www.pathologyoutlines.com/topic/stainsini1.html) (retained), [ERG](https://www.pathologyoutlines.com/topic/stainsERG.html), [CD31](https://www.pathologyoutlines.com/topic/cdmarkerscd31.html), [CD34](https://www.pathologyoutlines.com/topic/cdmarkerscd34.html), [S100](https://www.pathologyoutlines.com/topic/stainss100.html), [HMB45](https://www.pathologyoutlines.com/topic/stainshmb45.html), [MelanA](https://www.pathologyoutlines.com/topic/stainsmart1.html), [CD117](https://www.pathologyoutlines.com/topic/stainsmart1.html), [DOG1](https://www.pathologyoutlines.com/topic/stainsDOG1.html), [TTF1](https://www.pathologyoutlines.com/topic/stainsttf1.html), [HepPar1](https://www.pathologyoutlines.com/topic/stainsheppar1.html), [BCL2](https://www.pathologyoutlines.com/topic/stainsbcl2.html), [ALK](https://www.pathologyoutlines.com/topic/stainsalk.html), [STAT6](https://www.pathologyoutlines.com/topic/stainsstat6.html), [CD21](https://www.pathologyoutlines.com/topic/cdmarkerscd21.html), [CD35](https://www.pathologyoutlines.com/topic/cdmarkerscd30to39.html#cd35286665), [CD45](https://www.pathologyoutlines.com/topic/cdmarkerscd45.html) ([Mod Pathol 2020;33:456](31383964))"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-15",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Electron microscopy description",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#electronmicroscopydescription216255",
    "clean_content": "Electron microscopy description\n\n* Nonspecific findings; occasional desmosomes, perinuclear tonofilaments and abundant rough endoplasmic reticulum ([Mod Pathol 2020;33:456](31383964))"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-16",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#molecularcytogeneticsdescription216257",
    "clean_content": "Molecular / cytogenetics description\n\n* No recurrent somatic mutations, amplifications or deletions in any known oncogenes or suppressor genes ([Mod Pathol 2020;33:456](31383964))* Activation or enrichment of pathways related to the extracellular matrix, tight junctions, adherens junctions and TGFÎ² signaling by Gene Set Enrichment Analysis ([Mod Pathol 2020;33:456](31383964))* A unique cluster by unsupervised analysis of the methylation profiles ([Mod Pathol 2020;33:456](31383964))"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-17",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Molecular / cytogenetics images",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#molecularcytogeneticsimages216258",
    "clean_content": "Molecular / cytogenetics images\n\nImages hosted on other servers:  \n\n[![Genomic and transcriptomic characterization](https://www.pathologyoutlines.com/thumb/pancreassclerosingepitpmc02.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000300/figure/F5/)\n\nGenomic and transcriptomic characterization"
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-18",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#samplepathologyreport216260",
    "clean_content": "Sample pathology report\n\n* Pancreas and duodenum, pancreaticoduodenectomy:\n  + Sclerosing epithelioid mesenchymal neoplasm (see comment)+ Comment: The tumor is confined to the pancreatic parenchyma and measures 2.2 cm in greatest dimension. Adjacent pancreas reveals atrophy. Surgical margins are free of tumor. 16 benign lymph nodes are identified (0/16)."
  },
  {
    "id": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt-19",
    "source_document": "sclerosing-epithelioid-mesenchymal-neoplasm_34012_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreassclerosingepit.html#differentialdiagnosis216261",
    "clean_content": "Differential diagnosis\n\n* [Solid pseudopapillary neoplasm](https://www.pathologyoutlines.com/topic/pancreassolidpseudo.html):\n  + Pseudopapillae, areas of macrophages, hyaline globules and nuclear grooves+ Abnormal [beta catenin](https://www.pathologyoutlines.com/topic/stainsbetacatenin.html) and nuclear [progesterone receptor](https://www.pathologyoutlines.com/topic/stainsprog.html) expression+ *CTNNB1* mutations* [Sarcomatoid carcinoma](https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html):\n    + Larger infiltrative tumors with considerable pleomorphism, necrosis and proliferative activity+ Glandular component may be present+ *KRAS, TP53, SMAD4, CDKN2A* mutations* [Sclerosing epithelioid fibrosarcoma](https://www.pathologyoutlines.com/topic/softtissuesclerosingepithelioidfibrosarcoma.html):\n      + [MUC4](https://www.pathologyoutlines.com/topic/stainsmuc2.html#muc4) expression+ *EWSR1-CREB3L1, FUS-CREB3L21* or *FUS-CREB3L2* fusions* [Solitary fibrous tumor](https://www.pathologyoutlines.com/topic/softtissuesft.html):\n        + Ovoid to spindle shaped tumor cells with patternless pattern and staghorn-like vessels+ [CD34](https://www.pathologyoutlines.com/topic/cdmarkerscd34.html), [BCL2](https://www.pathologyoutlines.com/topic/stainsbcl2.html), [CD99](https://www.pathologyoutlines.com/topic/cdmarkerscd99.html) and nuclear [STAT6](https://www.pathologyoutlines.com/topic/stainsstat6.html) expression+ *NAB2-STAT6* fusion* [Inflammatory myofibroblastic tumor](https://www.pathologyoutlines.com/topic/softtissueinflammyofibro.html):\n          + Loose fascicles of uniform, plump spindle cells with inflammatory infiltrate+ [ALK](https://www.pathologyoutlines.com/topic/stainsalk.html), [ROS1](https://www.pathologyoutlines.com/topic/stainsros1.html), [SMA](https://www.pathologyoutlines.com/topic/stainsalphasmoothmuscleactin.html), [desmin](https://www.pathologyoutlines.com/topic/stainsdesmin.html) expression+ *ALK* or *ROS1* fusions* [Perivascular epithelioid cell neoplasm (PEComa)](https://www.pathologyoutlines.com/topic/uterusPEComa.html):\n            + Smooth muscle ([SMA](https://www.pathologyoutlines.com/topic/stainsalphasmoothmuscleactin.html), [desmin](https://www.pathologyoutlines.com/topic/stainsdesmin.html), [calponin](https://www.pathologyoutlines.com/topic/stainscalponin.html), [caldesmon](https://www.pathologyoutlines.com/topic/stainscaldesmon.html)) and melanocytic marker ([HMB45](https://www.pathologyoutlines.com/topic/stainshmb45.html), [MelanA](https://www.pathologyoutlines.com/topic/stainsmart1.html)) expression+ *TSC1 / TSC2* mutations* [Gastrointestinal stromal tumor](https://www.pathologyoutlines.com/topic/stomachGIST.html):\n              + [CD117](https://www.pathologyoutlines.com/topic/stainsmart1.html), [DOG1](https://www.pathologyoutlines.com/topic/stainsDOG1.html) and [CD34](https://www.pathologyoutlines.com/topic/cdmarkerscd34.html) expression+ *KIT* or *PDGFRA* mutations"
  }
]